Out of 17 untreated RRMS patients included in a previous study, 4 patients responded to myelin basic protein (MBP) with CD4+ T-cell proliferation (sub-study 1 population)[21]. The gene discussed is MBP; the disease is relapsing-remitting multiple sclerosis.